Literature DB >> 12534603

Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-98.

A Nieto1, M Ruiz-Ramos, L Abdel-Kader, M Conde, F Camacho.   

Abstract

BACKGROUND: Cutaneous malignant melanoma (CMM) morbidity and mortality rates have increased over the past several decades all around the world, but some developed countries have experienced recent declines in mortality from CMM among the young and middle-aged and even a reversal in the long-term increase in deaths attributable to CMM.
OBJECTIVES: To describe CMM mortality trends, by age and gender, in Spain between 1975 and 1998.
METHODS: Crude, age-adjusted, truncated, cumulative, age-specific and potential years of life lost rates of CMM mortality were calculated by gender. Age and period Poisson regression models were fitted to gender- and age-specific CMM mortality rates.
RESULTS: In males there were marked increases in all CMM mortality rates between 1975 and 1994, followed by their decrease during 1995-98. In contrast, rates rose in females between 1975 and 1998. There were annual increases of 13% in the risk of dying among males and 33% among females. Relative risks of CMM mortality increased with age in both genders: (i) 21.75 (95% confidence interval, CI 17.32-27.30) in males, and (ii) 28.27 (95% CI 24.99-31.97) in females in the > or = 70-year-old group, when compared with those < 35 years.
CONCLUSIONS: CMM mortality rates continue to rise in females while males have experienced a recent reversal of this trend in Spain. Emphasizing the danger of overexposure to ultraviolet radiation may be especially important in females.

Entities:  

Mesh:

Year:  2003        PMID: 12534603     DOI: 10.1046/j.1365-2133.2003.04990.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  Melanoma incidence increases in the elderly of Catalonia but not in the younger population: effect of prevention or consequence of immigration?

Authors:  Susana Puig; Joaquim Marcoval; Cristina Paradelo; Antoni Azon; Ramon Bartralot; Susana Bel; Xavier Bigata; Aram Boada; Antoni Campoy; Cristina Carrera; Neus Curco; Joan Dalmau; Carlos Ferrándiz; Josep R Ferreres; Manel Formigon; Fernando Gallardo; Alberto Gonzalez; Miquel Just; Enric Llistosella; Rosa M Marti; M Elena Nogues; Ramon Pedragosa; Josep A Pujol; Rodrigo Roldán-Marín; Mireia Sabat; Montserrat Salleras; Juan A Smandia; Pedro Zaballos; Estel Plana; Josep Malvehy
Journal:  Acta Derm Venereol       Date:  2015-04       Impact factor: 4.437

Review 2.  Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature.

Authors:  Gery P Guy; Donatus U Ekwueme
Journal:  Pharmacoeconomics       Date:  2011-10       Impact factor: 4.981

3.  Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011.

Authors:  Olaf Schoffer; Stefanie Schülein; Gerlinde Arand; Hans Arnholdt; Dieter Baaske; Ralf C Bargou; Nikolaus Becker; Matthias W Beckmann; Yves Bodack; Beatrix Böhme; Tayfun Bozkurt; Regine Breitsprecher; Andre Buchali; Elke Burger; Ulrike Burger; Klaus Dommisch; Gudrun Elsner; Karin Fernschild; Ulrike Flintzer; Uwe Funke; Michael Gerken; Hubert Göbel; Norbert Grobe; Vera Gumpp; Lucie Heinzerling; Lana Raffaela Kempfer; Alexander Kiani; Monika Klinkhammer-Schalke; Sabine Klöcking; Ute Kreibich; Katrin Knabner; Peter Kuhn; Stine Lutze; Uwe Mäder; Tanja Maisel; Jan Maschke; Martin Middeke; Andreas Neubauer; Antje Niedostatek; Anabelle Opazo-Saez; Christoph Peters; Beatrice Schell; Gerhard Schenkirsch; Harald Schmalenberg; Peter Schmidt; Constanze Schneider; Birgit Schubotz; Anika Seide; Paul Strecker; Sabine Taubenheim; Matthias Wackes; Steffen Weiß; Claudia Welke; Carmen Werner; Christian Wittekind; Jörg Wulff; Heike Zettl; Stefanie J Klug
Journal:  BMC Cancer       Date:  2016-12-05       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.